Zacks Investment Research has recently initiated coverage of Utah Medical Products, Inc. UTMD with a Neutral recommendation. This report highlights the company's strong positioning in the growing ...

SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that ...

The OUS (Outside the U.S.) Distributor category (item 2 above) included UTMD's China distributor for blood pressure monitoring kits for which 2024 shipments were $2.4 million compared to $4.0 million ...

We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and ...

Utah Medical Products Inc. Annual cash flow by MarketWatch. View UTMD net cash flow, operating cash flow, operating expenses and cash dividends.

SALT LAKE CITY, UT / ACCESS Newswire / July 24, 2025 / Utah Medical Products, Inc. [Nasdaq:UTMD] reports second calendar quarter (2Q) and first half (1H) 2025 financial results which are consistent ...

Utah Medical Products is financially healthy with no debt, strong profitability, and a 2.23% dividend yield, but faces significant revenue and margin challenges. Tariffs and potential recession-driven ...

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up more than the market average. Unfortunately for shareholders, while the Utah ...

1 Day UTMD 0.24% DJIA -0.20% Russell 2K -0.50% Health Care/Life Sciences -0.42% ...